1. Home
  2. GBDC vs AMRX Comparison

GBDC vs AMRX Comparison

Compare GBDC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

HOLD

Current Price

$13.57

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.68

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBDC
AMRX
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.8B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GBDC
AMRX
Price
$13.57
$12.68
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$14.83
$13.25
AVG Volume (30 Days)
2.0M
1.8M
Earning Date
02-03-2026
10-30-2025
Dividend Yield
11.50%
N/A
EPS Growth
4.09
N/A
EPS
1.42
0.02
Revenue
$870,777,000.00
$2,934,959,000.00
Revenue This Year
N/A
$9.99
Revenue Next Year
N/A
$6.67
P/E Ratio
$9.58
$671.35
Revenue Growth
20.16
9.50
52 Week Low
$12.68
$6.69
52 Week High
$16.01
$13.01

Technical Indicators

Market Signals
Indicator
GBDC
AMRX
Relative Strength Index (RSI) 41.32 58.74
Support Level $13.44 $12.81
Resistance Level $13.65 $12.99
Average True Range (ATR) 0.20 0.25
MACD -0.02 -0.01
Stochastic Oscillator 24.77 62.36

Price Performance

Historical Comparison
GBDC
AMRX

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: